- Home
- CELZ vs EVOK Comparison
CELZ vs EVOK Comparison
Compare CELZ & EVOK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CELZ
- EVOK
- Stock Information
- Founded
- CELZ 1998
- EVOK 2007
- Country
- CELZ United States
- EVOK United States
- Employees
- CELZ N/A
- EVOK N/A
- Industry
- CELZ Biotechnology: Pharmaceutical Preparations
- EVOK Biotechnology: Pharmaceutical Preparations
- Sector
- CELZ Health Care
- EVOK Health Care
- Exchange
- CELZ Nasdaq
- EVOK Nasdaq
- Market Cap
- CELZ 4.7M
- EVOK 4.2M
- IPO Year
- CELZ N/A
- EVOK 2013
- Fundamental
- Price
- CELZ $3.00
- EVOK $5.25
- Analyst Decision
- CELZ
- EVOK
- Analyst Count
- CELZ 0
- EVOK 0
- Target Price
- CELZ N/A
- EVOK N/A
- AVG Volume (30 Days)
- CELZ 11.1K
- EVOK 41.3K
- Earning Date
- CELZ 11-12-2024
- EVOK 11-07-2024
- Dividend Yield
- CELZ N/A
- EVOK N/A
- EPS Growth
- CELZ N/A
- EVOK N/A
- EPS
- CELZ N/A
- EVOK N/A
- Revenue
- CELZ $17,000.00
- EVOK $7,525,709.00
- Revenue This Year
- CELZ N/A
- EVOK $124.10
- Revenue Next Year
- CELZ N/A
- EVOK $75.70
- P/E Ratio
- CELZ N/A
- EVOK N/A
- Revenue Growth
- CELZ N/A
- EVOK 110.79
- 52 Week Low
- CELZ $2.65
- EVOK $3.54
- 52 Week High
- CELZ $10.28
- EVOK $17.88
- Technical
- Relative Strength Index (RSI)
- CELZ 44.19
- EVOK 59.82
- Support Level
- CELZ $2.94
- EVOK $4.51
- Resistance Level
- CELZ $3.15
- EVOK $5.35
- Average True Range (ATR)
- CELZ 0.22
- EVOK 0.50
- MACD
- CELZ -0.01
- EVOK 0.10
- Stochastic Oscillator
- CELZ 41.15
- EVOK 59.89
About CELZ Creative Medical Technology Holdings Inc.
Creative Medical Technology Holdings Inc is a biotechnology holding company focused on regenerative medicine. It is formed for the purpose of creating and licensing intellectual property in the area of amniotic fluid derived stem cells for therapeutic applications. Its core activity is stem cell research and the development of applications for use to treat male and female sexual dysfunction, infertility, miscarriages, and related issues.
About EVOK Evoke Pharma Inc.
Evoke Pharma Inc is a specialty pharmaceutical company focused on the development and commercialization of drugs to treat gastrointestinal, or GI, disorders, and diseases. The company's product Gimoti is an investigational metoclopramide nasal spray for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in women. Gimoti is a novel nasal spray formulation of metoclopramide designed to provide systemic delivery of the molecule through the nasal mucosa.